CytoSorb adsorption for reducing risk of bleeding during cardiac surgery in Ticagrelor/Rivaroxaban
- Cardiac Surgery
CytoSorb adsorption for reducing risk of bleeding during cardiac surgery in Ticagrelor/Rivaroxaban treated patients
Chairs: Dr. Nandor Marczin, London/UK and Stefan Baudis, CytoSorbents Europe GmbH, Berlin/Germany
NICE Medtech Innovation Briefing review
Dr. Nandor Marczin, Senior lecturer, consultant cardiothoracic anaesthetist Imperial College London; Brompton Harefield NHS Trust, UK
How bleeding complications and costs can be reduced
Dr. Stephan Geidel, Asklepios Hospital St. George, Hamburg/Germany
Share
|
CytoSorb adsorption for reducing risk of bleeding during cardiac surgery in Ticagrelor/Rivaroxaban
- April 21, 2021
- Cardiac Surgery
Share
|
CytoSorb adsorption for reducing risk of bleeding during cardiac surgery in Ticagrelor/Rivaroxaban treated patients
Chairs: Dr. Nandor Marczin, London/UK and Stefan Baudis, CytoSorbents Europe GmbH, Berlin/Germany
NICE Medtech Innovation Briefing review
Dr. Nandor Marczin, Senior lecturer, consultant cardiothoracic anaesthetist Imperial College London; Brompton Harefield NHS Trust, UK
How bleeding complications and costs can be reduced
Dr. Stephan Geidel, Asklepios Hospital St. George, Hamburg/Germany
More Videos
